5 results about "Babesia" patented technology

The present invention relates to a Babesia antigen comprising at least a portion of a gametocyte HAPLESS2 / GCS1 (HAP2) protein, vectors and cells expressing such antigen, compositions and kits comprising such antigens, and methods of using such antigens to interfere with the Babesia transmission by competent ticks.

The present disclosure provides immunogenic compositions and methods for vaccination with a CelTOS immunogen. The immunogenic composition comprises Babesia, Theileria or Cytauxzoon CelTOS. The immunogenic composition may also comprise CelTOS with structural changes that affect immune recognition.

The invention belongs to the field of life medicine science, and particularly relates to application of iron nanoparticles in preparation of a product for preventing and treating babesia. The iron nanoparticles are polysaccharide superparamagnetic iron oxide injection or other molded products containing main curative effect components of the polysaccharide superparamagnetic iron oxide injection, and the iron nanoparticles are applied to an object in the presence of a magnetic field. Tests prove that the iron nanoparticles have a good control effect on babesia with weak fecundity under the action of an external magnetic field.

The disclosure, in some aspects, provides a composition comprising labelled and / or tagged and / or bound amino acid sequences useful for the detection of Babesia species. Also disclosed are methods for the detection of infection by one or more Babesia species.

The present disclosure relates to methods of treating infections caused by one or more protozoa such as Cryptosporidium, Eimeria, Babesia and Toxoplasma comprising administering to a subject in need thereof an effective amount of an inhibitor of plasmepsin IX and / or X selected from compounds disclosed herein.